Linked Life Data

7522874

Source:http://linkedlifedata.com/resource/pubmed/id/7522874

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1994-11-1
pubmed:abstractText
To examine the long-term survival of a group of patients with non-seminomatous germ cell tumours, who relapse after chemotherapy and are retreated with a cisplatin and etoposide-based regimen.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0007-1331
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
225-30
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:7522874-Adolescent, pubmed-meshheading:7522874-Adult, pubmed-meshheading:7522874-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7522874-Bleomycin, pubmed-meshheading:7522874-Cisplatin, pubmed-meshheading:7522874-Cyclophosphamide, pubmed-meshheading:7522874-Cytarabine, pubmed-meshheading:7522874-Dactinomycin, pubmed-meshheading:7522874-Etoposide, pubmed-meshheading:7522874-Genital Neoplasms, Male, pubmed-meshheading:7522874-Germinoma, pubmed-meshheading:7522874-Humans, pubmed-meshheading:7522874-Male, pubmed-meshheading:7522874-Methotrexate, pubmed-meshheading:7522874-Neoplasm Recurrence, Local, pubmed-meshheading:7522874-Prognosis, pubmed-meshheading:7522874-Retrospective Studies, pubmed-meshheading:7522874-Risk Factors, pubmed-meshheading:7522874-Survival Analysis, pubmed-meshheading:7522874-Time Factors, pubmed-meshheading:7522874-Vinblastine, pubmed-meshheading:7522874-Vincristine
pubmed:year
1994
pubmed:articleTitle
The long-term outcome of patients who relapse after chemotherapy for non-seminomatous germ cell tumours.
pubmed:affiliation
Department of Medical Oncology, Charing Cross Hospital, London, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't